ANI Pharmaceuticals
ANIP
ANIP
227 hedge funds and large institutions have $1.35B invested in ANI Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 63 increasing their positions, 75 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 75
38% less call options, than puts
Call options by funds: $535K | Put options by funds: $863K
Holders
227
Holding in Top 10
4
Calls
$535K
Puts
$863K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$12.1M | |
| 3 | +$11.1M | |
| 4 |
JP Morgan Chase
New York
|
+$10.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.82M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$13.2M | |
| 3 | -$12.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.9M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$7.62M |